- Home
- AMBP vs NNNN Comparison
AMBP vs NNNN Comparison
Compare AMBP & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- NNNN
- Stock Information
- Founded
- AMBP 2021
- NNNN 2021
- Country
- AMBP Luxembourg
- NNNN Germany
- Employees
- AMBP N/A
- NNNN N/A
- Industry
- AMBP Containers/Packaging
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMBP Industrials
- NNNN Health Care
- Exchange
- AMBP Nasdaq
- NNNN Nasdaq
- Market Cap
- AMBP 2.0B
- NNNN 2.2B
- IPO Year
- AMBP N/A
- NNNN 2025
- Fundamental
- Price
- AMBP $3.75
- NNNN $20.91
- Analyst Decision
- AMBP Hold
- NNNN
- Analyst Count
- AMBP 6
- NNNN 0
- Target Price
- AMBP $4.22
- NNNN N/A
- AVG Volume (30 Days)
- AMBP 1.2M
- NNNN 34.8K
- Earning Date
- AMBP 10-23-2025
- NNNN 04-28-2026
- Dividend Yield
- AMBP 10.67%
- NNNN N/A
- EPS Growth
- AMBP N/A
- NNNN N/A
- EPS
- AMBP N/A
- NNNN 0.06
- Revenue
- AMBP $5,346,000,000.00
- NNNN $8,185,146.00
- Revenue This Year
- AMBP $13.06
- NNNN N/A
- Revenue Next Year
- AMBP $2.96
- NNNN N/A
- P/E Ratio
- AMBP N/A
- NNNN $398.99
- Revenue Growth
- AMBP 10.34
- NNNN 21.95
- 52 Week Low
- AMBP $2.50
- NNNN $5.18
- 52 Week High
- AMBP $4.78
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- AMBP 57.39
- NNNN 44.83
- Support Level
- AMBP $3.72
- NNNN $20.00
- Resistance Level
- AMBP $3.65
- NNNN $29.38
- Average True Range (ATR)
- AMBP 0.10
- NNNN 3.65
- MACD
- AMBP 0.03
- NNNN 0.45
- Stochastic Oscillator
- AMBP 92.00
- NNNN 41.87
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.